Complex adaptive therapeutic strategy (CATS) for cancer

Journal of Controlled Release

Volumn 175, Issue 1, 2014, Pages 43-47

  Cho, Yong Woo ^a,b   Kim, Sang Yoon ^a,c,d   Kwon, Ick Chan ^a,e   Kim, In San ^a,f  

^a Korea Institute of Science and Technology   (South Korea)

^b Hanyang University   (South Korea)

^c Asan Medical Center   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e Korea University   (South Korea)

^f Kyungpook National University School of Medicine   (South Korea)

Author keywords

Cancer immunotherapy; Complex adaptive system (CAS); Induced phenotype; Nanoparticle; Tumor heterogeneity; Tumor network

Indexed keywords

ANTI-CANCER THERAPIES; CANCER IMMUNOTHERAPY; COMPLEX ADAPTIVE SYSTEMS; INDUCED PHENOTYPE; INTERMEDIATE CONCEPT; THERAPEUTIC STRATEGY; TUMOR HETEROGENEITY; TUMOR MICROENVIRONMENTS;

ADAPTIVE SYSTEMS; CLONE CELLS; COMPLEX NETWORKS; DISEASES; NANOPARTICLES;

TUMORS;

ANTINEOPLASTIC AGENT; NANOPARTICLE;

ADAPTATION; APOPTOSIS; ARTICLE; ARTIFACT; CANCER CELL; CANCER IMMUNOTHERAPY; CANCER THERAPY; COMPLEX ADAPTIVE THERAPEUTIC STRATEGY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; EVOLUTION; EXOSOME; GENE MUTATION; IMMUNOSUPPRESSIVE TREATMENT; MOLECULARLY TARGETED THERAPY; NEOPLASM; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; THROMBOSIS; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

CANCER IMMUNOTHERAPY; COMPLEX ADAPTIVE SYSTEM (CAS); INDUCED PHENOTYPE; NANOPARTICLE; TUMOR HETEROGENEITY; TUMOR NETWORK;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNOTHERAPY; NANOPARTICLES; NEOPLASMS;

EID: 84891773419     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.12.017     Document Type: Article

References (27)

1. T.A. Denison, and Y.H. Bae Tumor heterogeneity and its implication for drug delivery J. Control. Release 164 2012 187 191
2. M.R. Junttila, and F.J. de Sauvage Influence of tumour micro-environment heterogeneity on the therapeutic response Nature 501 2013 346 354
3. A. Marusyk, and K. Polyak Tumor heterogeneity: causes and consequences Biochim. Biophys. Acta 1805 2010 105 117
4. J.H. Holland Studying complex adaptive systems J. Syst. Sci. Complex. 19 2006 1 8
5. E.D. Schwab, and K.J. Pienta Cancer as a complex adaptive system Med. Hypotheses 47 1996 235 241
6. J. Du, M.A. Meledeo, Z. Wang, H.S. Khanna, V.D.P. Paruchuri, and K.J. Yarema Metabolic glycoengineering: sialic acid and beyond Glycobiology 19 2009 1382 1401
7. T. Yu, Z. Wang, and T.J. Mason A review of research into the uses of low level ultrasound in cancer therapy Ultrason. Sonochem. 11 2004 95 103
8. M. Verheij, and H. Bartelink Radiation-induced apoptosis Cell Tissue Res. 301 2000 133 142
9. X.-X. Zhang, H.S. Eden, and X. Chen Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates J. Control. Release 159 2012 2 13
10. E.-J. Cha, E.S. Jang, I.-C. Sun, I.J. Lee, J.H. Ko, Y.I. Kim, I.C. Kwon, K. Kim, and C.-H. Ahn Development of MRI/NIRF 'activatable' multimodal imaging probe based on iron oxide nanoparticles J. Control. Release 155 2011 152 158
11. S. Wang, I.S. Shin, H. Hancock, B.-S. Jang, H.-S. Kim, S.M. Lee, V. Zderic, V. Frenkel, I. Pastan, C.H. Paik, and M.R. Dreher Pulsed high intensity focused ultrasound increases penetration and therapeutic efficacy of monoclonal antibodies in murine xenograft tumors J. Control. Release 162 2012 218 224
12. B. Diop-Frimpong, V.P. Chauhan, S. Krane, Y. Boucher, and R.K. Jain Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors Proc. Natl. Acad. Sci. U. S. A. 108 2011 2909 2914
13. C. Wong, T. Stylianopoulos, J. Cui, J. Martin, V.P. Chauhan, W. Jiang, Z. Popovíc, R.K. Jain, M.G. Bawendi, and D. Fukumura Multistage nanoparticle delivery system for deep penetration into tumor tissue Proc. Natl. Acad. Sci. U. S. A. 108 2011 2426 2431
14. E. Ben-Jacob, D. Coffey, and H. Levine Bacterial survival strategies suggest rethinking cancer cooperativity Trends Microbiol. 20 2012 403 410
15. S.M. van Dommelen, P. Vader, S. Lakhal, S.A.A. Kooijmans, W.W. van Solinge, M.J.A. Wood, and R.M. Schiffelers Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery J. Control. Release 161 2012 635 644
16. M. Simons, and G. Raposo Exosomes - vesicular carriers for intercellular communication Curr. Opin. Cell Biol. 21 2009 575 581
17. X. Lu, and Y. Kang Cell fusion as a hidden force in tumor progression Cancer Res. 69 2009 8536 8539
18. R.D. Schreiber, L.J. Old, and M.J. Smyth Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion Science 331 2011 1565 1570
19. M.D. Vesely, and R.D. Schreiber Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy Ann. N. Y. Acad. Sci. 1284 2013 1 5
20. M.P. Chao, I.L. Weissman, and R. Majeti The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications Curr. Opin. Immunol. 24 2012 225 232
21. C.Z. Han, and K.S. Ravichandran Metabolic connections during apoptotic cell engulfment Cell 147 2011 1442 1445
22. M.R. Elliott, and K.S. Ravichandran Clearance of apoptotic cells: implications in health and disease J. Cell Biol. 189 2010 1059 1070
23. F. Winau, O. Westphal, and R. Winau Paul Ehrlich - in search of the magic bullet Microbes Infect. 6 2004 786 789
24. V.J. Venditto, and F.C. Szoka Jr. Cancer nanomedicines: so many papers and so few drugs! Adv. Drug Deliv. Rev. 65 2013 80 88
25. Y.H. Bae, and K. Park Targeted drug delivery to tumors: myths, reality and possibility J. Control. Release 153 2011 198 205
26. I.K. Keun, S.C. Lee, B. Han, and K. Park Analysis on the current status of targeted drug delivery to tumors J. Control. Release 164 2012 108 114
27. K. Park Facing the truth about nanotechnology in drug delivery ACS Nano 7 2013 7442 7447